CLOVERNA Inc.
PrivateLast Round
Pre Seed
Jun 30, 2022
Total Funding Raised
$734,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CLOVERNA Inc. is a biotechnology company that develops RNA-targeted drug discovery technology to identify therapeutic targets for rare and intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CLOVERNA Inc. Comparables
Compare CLOVERNA Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reborna Biosciences, Inc. | 83% | |
| ReviR Therapeutics | 79% | |
| HAYA Therapeutics | 78% |
CLOVERNA Inc. Funding Rounds
Historical fundraising activity
CLOVERNA Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Apr 17, 2026
Monthly visitors increased 114% MoM.
CLOVERNA Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CLOVERNA Inc.'s valuation, stock price, and market status.
Is CLOVERNA Inc. a public or private company?
CLOVERNA Inc. is a private company.
What is the current stock price of CLOVERNA Inc.?
CLOVERNA Inc. is a private company, so its shares have no public market price. Caplight tracks CLOVERNA Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CLOVERNA Inc. worth (valuation)?
Valuation information for CLOVERNA Inc. is not publicly available.
Can I buy CLOVERNA Inc. stock?
CLOVERNA Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CLOVERNA Inc.'s last funding round?
CLOVERNA Inc.'s most recent funding round was Pre Seed on June 30, 2022.
Who are the main investors in CLOVERNA Inc.?
Key investors in CLOVERNA Inc. include Keio Innovation Initiative.
Will CLOVERNA Inc. IPO soon?
No public IPO plans have been announced for CLOVERNA Inc..
How can I track CLOVERNA Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CLOVERNA Inc.'s shares on secondary markets.